Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.3K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.3K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

4.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
Tissue Transplantation01:24

Tissue Transplantation

1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experiences and perspectives of patients and clinicians in nurse-led clinics in an oncological setting: A sequential multi-methods study.

European journal of oncology nursing : the official journal of European Oncology Nursing Society·2022
Same author

Needs and preferences among patients with high-grade glioma and their caregivers - A longitudinal mixed methods study.

European journal of cancer care·2018
Same author

Erratum to: Associations between adherence, depressive symptoms and health-related quality of life in young adults with cystic fibrosis.

SpringerPlus·2017
Same author

Associations between adherence, depressive symptoms and health-related quality of life in young adults with cystic fibrosis.

SpringerPlus·2016
Same author

Randomized controlled trial of the Valencia model of waking hypnosis plus CBT for pain, fatigue, and sleep management in patients with cancer and cancer survivors.

Psycho-oncology·2016
Same author

Physician-diagnosed depression and suicides in pediatric hematopoietic cell transplant survivors with up to 40 years of follow-up.

Bone marrow transplantation·2015
Same journal

ALLOPLUS: allogeneic hematopoietic stem cell transplantation in children and adult people living with human immunodeficiency virus, a retrospective study of the SFGM-TC.

Bone marrow transplantation·2026
Same journal

Epigenetic priming with azacitidine-BEAM versus decitabine-BEAM conditioning for autologous transplantation in non-Hodgkin's lymphoma.

Bone marrow transplantation·2026
Same journal

CHIME: a novel HLA eplet model associates with non-relapse mortality in haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.

Bone marrow transplantation·2026
Same journal

Transplant outcomes for patients with severe acquired aplastic anemia over the age of 40 using busulfan, fludarabine, reduced-dose cyclophosphamide, and anti-thymocyte globulin conditioning regimen.

Bone marrow transplantation·2026
Same journal

A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

Bone marrow transplantation·2026
Same journal

Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

Bone marrow transplantation·2026
See all related articles

Related Experiment Video

Updated: Mar 25, 2026

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

16.1K

Sexual function 1-year after allogeneic hematopoietic stem cell transplantation.

K H Noerskov1, I Schjødt1, K L Syrjala2

  • 1Department of Hematology, Bone Marrow Transplantation Unit, Rigshospitalet University Hospital, Copenhagen University Hospital, Copenhagen, Denmark.

Bone Marrow Transplantation
|February 16, 2016
PubMed
Summary
This summary is machine-generated.

Allogeneic hematopoietic stem cell transplantation (HSCT) significantly impairs sexual function in men and women one year post-treatment. This sexual dysfunction impacts body image, anxiety, and depression, necessitating routine evaluation and care.

More Related Videos

Application of Aorta-gonad-mesonephros Explant Culture System in Developmental Hematopoiesis
07:38

Application of Aorta-gonad-mesonephros Explant Culture System in Developmental Hematopoiesis

Published on: November 3, 2017

9.0K
Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells
06:41

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

Published on: May 19, 2023

2.8K

Related Experiment Videos

Last Updated: Mar 25, 2026

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

16.1K
Application of Aorta-gonad-mesonephros Explant Culture System in Developmental Hematopoiesis
07:38

Application of Aorta-gonad-mesonephros Explant Culture System in Developmental Hematopoiesis

Published on: November 3, 2017

9.0K
Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells
06:41

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

Published on: May 19, 2023

2.8K

Area of Science:

  • Oncology
  • Hematology
  • Reproductive Medicine

Background:

  • Allogeneic hematopoietic stem cell transplantation (HSCT) is a life-saving procedure but carries significant short and long-term toxicities.
  • Sexual dysfunction is a recognized but often under-addressed toxicity following HSCT.
  • The impact of HSCT on sexual functioning, body image, anxiety, and depression requires further prospective investigation.

Purpose of the Study:

  • To prospectively evaluate the prevalence and impact of sexual dysfunction one year after allogeneic HSCT.
  • To determine associations between sexual dysfunction and psychological factors including body image, anxiety, and depression post-HSCT.
  • To assess the influence of chronic graft-versus-host disease (GVHD) on sexual function after HSCT.

Main Methods:

  • A controlled prospective cohort study involving 124 patients before HSCT and 63 patients one year after HSCT.
  • Utilized validated questionnaires: Sexual Functioning Questionnaire, Body Image Scale, and Hospital Anxiety and Depression Scale.
  • Collected descriptive data and assessed sexual function, body image, anxiety, and depression at two time points.

Main Results:

  • A significant decline in overall sexual function was observed in both men (P<0.001) and women (P=0.010) one year post-HSCT.
  • 47% of men and 60% of women reported at least one physical sexual problem one year after HSCT.
  • Women with chronic GVHD reported significantly lower sexual function compared to those without (P=0.008).

Conclusions:

  • Sexual dysfunction is a prevalent and persistent issue for both men and women one year following allogeneic HSCT.
  • Sexual dysfunction is associated with negative impacts on body image, anxiety, and depression.
  • Routine screening and management of sexual dysfunction are crucial components of post-HSCT care.